Literature DB >> 19017894

Effect of depression care on outcomes in COPD patients with depression.

Neil Jordan1, Todd A Lee2, Marcia Valenstein3, Paul A Pirraglia4, Kevin B Weiss5.   

Abstract

BACKGROUND: Although depression among COPD patients is a common problem with important consequences for the management of COPD and overall outcomes, the proportion of those who receive guideline-concordant depression care is low. Guideline-concordant depression care is associated with fewer depressive symptoms and lower risk for psychiatric hospitalization; however, it is unknown whether guideline-concordant depression care favorably impacts COPD-related outcomes for patients with both conditions.
METHODS: This retrospective cohort study investigated 5,517 veterans with COPD who experienced a new treatment episode for depression. Guideline-concordant depression care was defined as having an adequate supply of antidepressant medication and sufficient follow-up care. Multivariate methods were used to examine the relationship between the receipt of guideline-concordant depression care and (1) COPD-related hospitalization and (2) all-cause mortality 2 years after the depression episode, while controlling for care setting and other covariates.
RESULTS: There was no association between the receipt of guideline-concordant depression care and COPD-related hospitalization (odds ratio [OR], 0.98) or all-cause mortality (OR, 0.95). However, patients seen in mental health settings during their depressive episode had 30% lower odds of 2-year mortality than patients seen in primary care.
CONCLUSIONS: For patients with COPD and depression, interacting with a mental health professional may be an important intervention. However, receiving guideline-concordant depression care, as outlined in common quality monitors, was not significantly associated with decreased hospitalization or mortality. These findings suggest that more referrals to specialty care or better care coordination with mental health specialty care may lead to a significant reduction in mortality risk for these patients.

Entities:  

Mesh:

Year:  2008        PMID: 19017894     DOI: 10.1378/chest.08-0839

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Adherence and healthcare utilization among older adults with COPD and depression.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Ting-Ying Huang; Yu-Jung Wei; Ilene Harris; Patience Moyo; Peter Hur; Susan W Lehmann; Giora Netzer; Linda Simoni-Wastila
Journal:  Respir Med       Date:  2017-06-03       Impact factor: 3.415

Review 2.  Defining COPD-Related Comorbidities, 2004-2014.

Authors:  Carlos H Martinez; David M Mannino; Miguel J Divo
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

3.  The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study.

Authors:  Yu-Jung Wei; Linda Simoni-Wastila; Jennifer S Albrecht; Ting-Ying Huang; Patience Moyo; Bilal Khokhar; Ilene Harris; Patricia Langenberg; Giora Netzer; Susan W Lehmann
Journal:  Int J Geriatr Psychiatry       Date:  2017-08-22       Impact factor: 3.485

4.  Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jingjing Qian; Linda Simoni-Wastila; Patricia Langenberg; Gail B Rattinger; Ilene H Zuckerman; Susan Lehmann; Michael Terrin
Journal:  J Am Geriatr Soc       Date:  2013-04-25       Impact factor: 5.562

5.  Two Interventions for Patients with Major Depression and Severe Chronic Obstructive Pulmonary Disease: Impact on Dyspnea-Related Disability.

Authors:  George S Alexopoulos; Jo Anne Sirey; Samprit Banerjee; Danielle S Jackson; Dimitris N Kiosses; Cristina Pollari; Richard S Novitch; Amanda Artis; Patrick J Raue
Journal:  Am J Geriatr Psychiatry       Date:  2017-10-10       Impact factor: 4.105

6.  Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Jordi Cantoni; Karlos Naberan
Journal:  Lung       Date:  2014-01-30       Impact factor: 2.584

7.  Clinical characteristics and related risk factors of depression in patients with early COPD.

Authors:  Ji-Hoon Lee; Min A Park; Myung Jae Park; Yong Suk Jo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-15

Review 8.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.